//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
PostEmbed
ABBVIEAbbVie shares nine‑year CLL14 results for Venetoclax regimen in previously untreated chronic lymphocytic leukemiaAbbVie has reported final nine‑year data from the Phase 3 CLL14 study, which eval...
www.ipharmacenter.com
European Hematology Association (EHA) 2026 Congress | iPharmaCenter